Cancer Biomarker Detection With Luminex Assays
4.5 (654) · $ 21.99 · In stock
Luminex and Bio-Techne are working together to support the development of early diagnostic solutions that detect cancer earlier through the use of proteomics.
Charles Rosser, a research scientist and professor of biomedical sciences, has developed a multiplex test for early-stage bladder cancer using Luminex® xMAP® Technology. Bladder cancer affects over 570,000 people globally each year, and the Oncuria® test aims to detect bladder cancer, monitors for recurrence, and predicts which patients will benefit from the immunotherapy treatment. Current diagnostic assays lack sensitivity and do not provide a comprehensive view of the cancer’s molecular profile, but the Oncuria® test covers 10 glycoproteins to detect the biological signature of bladder cancer with sensitivity of 90% to 93% and specificity of 86% to 95%. The test received Breakthrough Device Designation status from the FDA and is currently available as a laboratory-developed test (LDT). In a recent clinical validation study involving about 350 patients, the test offered 93% sensitivity. Learn more about this major shift in the care of patients with bladder cancer.
Cytokine Detection with Multiplex Immunoassays Biocompare: The Buyer's Guide for Life Scientists
A) Diagram of Luminex based multiplex assays. Antibodies against
Luminex Discovery Assays R&D Systems, a Bio-Techne Brand
Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer [PeerJ]
Cancer Biomarker Detection With Luminex Assays
Luminex Assay Principle: R&D Systems
Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy
Luminex Cytokine Detection Service - Creative Proteomics
Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel
Cancers, Free Full-Text
How Luminex's XMAPTechnology helps cancer detection, Luminex Corporation - A Diasorin Company posted on the topic
Multi-biomarker panel signature as the key to diagnosis of ovarian cancer
Multiplex Cancer Assays for Cancer Biomarker Detection
Cancer Biomarker Detection With Luminex Assays
